China’s CanSino, Post-AstraZeneca Partnership, Pursues Additional Vaccine Contracts
CanSino Biologics, a prominent Chinese vaccine manufacturer, is actively seeking new vaccine contracts following its recent ...
Read moreCanSino Biologics, a prominent Chinese vaccine manufacturer, is actively seeking new vaccine contracts following its recent ...
Read moreLOS ANGELES - BioTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies, and ...
Read moreHOUSTON and SINGAPORE - Hummingbird Bioscience Holdings Limited, an innovative clinical-stage biotech company focused on developing precision therapies ...
Read more